atai Life Sciences (NASDAQ: ATAI), a trailblazer in the biopharmaceutical sector, is set to participate in the TD Cowen 45th Annual Health Care Conference in Boston, scheduled from March 3-5, 2025. The event will feature a fireside chat with atai’s management on March 3 at 11:50 A.M. ET, complemented by one-on-one investor meetings.

The fireside chat will be accessible via a webcast, with a replay available in the Investors section of atai’s website for up to 90 days post-event. This engagement underscores atai’s ongoing commitment to addressing the critical needs in mental health treatment through innovative, evidence-based therapeutics aimed at conditions such as depression and anxiety.

For additional details on atai’s pioneering work and their upcoming conference participation, visit www.atai.life.

Read official post